Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy

British Journal of Dermatology

Volumn 167, Issue 1, 2012, Pages 150-159

  Szeimies, Rolf Markus ^a   Torezan, L ^b   Niwa, A ^b   Valente, N ^b   Unger, P ^a   Kohl, E ^a   Schreml, S ^a   Babilas, P ^a   Karrer, S ^a   Festa Neto, C ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; INTERSTITIAL COLLAGENASE; PROCOLLAGEN; PROCOLLAGEN TYPE 1; PROTEIN P53; TENASCIN; UNCLASSIFIED DRUG;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ELASTOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RED LIGHT; SKIN BIOPSY; SKIN DEFECT;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CLINICAL PROTOCOLS; FACIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; OINTMENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN AGING;

EID: 84863334715     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10887.x     Document Type: Article

References (37)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer (Phila) 1953; 6:963-8.
2. Marks R. Malignant transformation of solar keratoses to SCC. Lancet 1988; 1:795-7. (Pubitemid 18094914)
3. Babilas P, Landthaler M, Szeimies RM. Actinic keratosis. Hautarzt 2003; 54:551-60.
4. Braakhuis BJM, Tabor MP, Kummer JA et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63:1727-30. (Pubitemid 36460827)
5. Kohl E, Torezan LAR, Landthaler M, Szeimies RM. Aesthetic effects of topical photodynamic therapy. J Eur Acad Dermatol Venereol 2010; 24:1-9.
6. Kohl E, Steinbauer J, Landthaler M, Szeimies RM. Skin ageing. J Eur Acad Dermatol Venereol 2011; 25:873-84.
7. Quan T, He T, Kang S et al. Solar ultraviolet radiation reduces collagen photoaged human skin by blocking transforming growth factor-β type II receptor/Smad signaling. Am J Pathol 2004; 165:741-51. (Pubitemid 39129282)
8. Dover JS, Bathia AC, Stewart B, Arndt KA. Topical 5-ALA combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005; 141:1247-52. (Pubitemid 41498922)
9. Szeimies RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-ALA in the treatment of actinic keratosis; a clinical and histological study. Dermatology 1996; 192:246-51. (Pubitemid 26139209)
10. Touma D, Yaar M, Whitehead S et al. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratosis and diffuse photodamage. Arch Dermatol 2004; 140:33-40. (Pubitemid 38090268)
11. Avram D, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004; 3 (Suppl.): 36-9.
12. Gold MH, Bradshaw VL, Boring MM et al. Split face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006; 32:795-803.
13. Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 2005; 7:21-4. (Pubitemid 40896747)
14. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003; 139:1313-20. (Pubitemid 37248282)
15. Braathen L, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for non melanoma skin cancer: an international consensus. J Am Acad Dermatol 2007; 56:125-43. (Pubitemid 44969292)
16. McCarthy M Jr, Chang CH, Pickard AS et al. Visual analog scales for assessing surgical pain. J Am Coll Surg 2005; 201:245-52. (Pubitemid 40994959)
17. Zane C, Capezera R, Sala R et al. Clinical and echographic analysis of PDT using MAL as sensitizer in the treatment of photodamaged facial skin. Lasers Surg Med 2007; 39:203-9. (Pubitemid 46623029)
18. Braathen LR, Paredes BE, Saksela O et al. Short incubation with methylaminolevulinate for photodynamic therapy of actinic keratosis. J Eur Acad Dermatol Venereol 2008; 23:550-5.
19. Kleinpenning MM, Van de Kerkhof PC, Gerritsen RM. The clinical efficacy of topical MAL-PDT in moderate to severe actinic keratoses of the face and scalp. J Dermatol Treat 2010; 21:252-7.
20. Apalla Z, Sotiriou E, Chovarda E et al. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br J Dermatol 2010; 162:171-5.
21. Sharfei S, Juzenas P, Moan J, Bissonnette R. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced tumors in mice. Arch Dermatol Res 2002; 294:237-42. (Pubitemid 34762299)
22. Bissonnette R. Chemopreventive thoughts for photodynamic therapy. Dermatol Clin 2007; 25:95-100.
23. Wulf HC, Pavel S, Stender I, Bakker-Wensveen CA. Topical photodynamic therapy for prevention of new skin lesions in renal transplant patients. J Eur Acad Dermatol Venereol 2006; 86:25-8. (Pubitemid 46939784)
24. Wennberg AM, Stenquist B, Stockfleth E. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 2008; 86:423-9.
25. Fink-Puches R, Wulf P. Long term follow-up and histological changes of superficial non-melanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 1998; 134:821-6. (Pubitemid 28350185)
26. Bagazgoitia L, Cuevas Santos J, Juarrantz A, Jaen P. Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. Br J Dermatol 2011; 165:144-51.
27. Orringer JS, Johnson TM, Kang S et al. Effect of carbon dioxide laser resurfacing on epidermal p53 immunostaining in photodamaged skin. Arch Dermatol 2004; 140:1073-7. (Pubitemid 39223114)
28. Berg RJW, Van Kraken HJ, Rebel HG et al. Early p-53 mutations in mouse skin carcinogenesis by UV-B radiation: immunohistochemical detection of mutant p-53 protein clusters of preneoplastic epidermal cells. Proc Natl Acad Sci USA 1996; 93:274-8. (Pubitemid 26038142)
29. Dang C, Gottschling M, Roewert J et al. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol 2006; 155:763-70. (Pubitemid 44352557)
30. Latijnhouwers M, Bergers M, Ponec M et al. Human epidermal keratinocytes are a source of tenascin-C during wound healing. J Invest Dermatol 1997; 108:776-83. (Pubitemid 27192353)
31. Latijnhouwers M, Pfundt R, De Jongh GJ, Schalkwijk J. Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway. Matrix Biol 1998; 17:305-16. (Pubitemid 28403344)
32. Almeida Issa MC, Maceira-Pineiro J, Farias RE et al. Immunohistochemical expression of matrix metalloproteinases in photodamaged skin by photodynamic therapy. Br J Dermatol 2009; 161:647-53.
33. Park MY, Sohn S, Lee ES, Kim YC. Photorejuvenation induced by 5-aminolevulinic acid photodynamic therapy in patients with actinic keratosis: histologic analysis. J Am Acad Dermatol 2010; 62:85-95.
34. Choi JY, Park GT, Na EY et al. Molecular changes following topical photodynamic therapy using methyl aminolaevulinate in mouse skin. J Dermatol Sci 2010; 58:198-203.
35. Orringer JS, Hammerberg C, Hamilton T et al. Molecular effects of photodynamic therapy for photoaging. Arch Dermatol 2008; 144:1296-302.
36. Karrer S, Bosserhoff AK, Weiderer P et al. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol 2004; 151:776-83. (Pubitemid 39482110)
37. Karrer S, Bosserhoff AK, Weiderer P et al. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol 2003; 120:325-31. (Pubitemid 36513085)